Login to Your Account

Street to Gilead: Hurry up already on dealmaking front

By Marie Powers
News Editor

Tuesday, July 26, 2016

Disappointing second-quarter earnings at Gilead Sciences Inc. forced shares (NASDAQ:GILD) down 8.5 percent Tuesday, closing at $81.05 for a loss of $7.50, and led to a chorus of calls for the company to pull the trigger on a big deal.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription